Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Premaitha LSE:NIPT London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 9.10 9.00 9.20 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 6.1 -9.5 3.0 3.0 38

Yourgene Health PLC Ranger(R) Technology to be presented at Labroots

28/10/2021 7:00am

RNS Non-Regulatory


Yourgene Health PLC

28 October 2021

Yourgene Health plc

("Yourgene" or the "Company")

Yourgene's Ranger(R) Technology to be presented at Labroots webinar

Manchester, UK - 28 October 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Ranger(R) Technology, which was acquired with Coastal Genomics Inc in August 2020, will be presented by Yourgene's strategic customer, Labcorp, at the Labroots 2021 Clinical Diagnostics and Research Virtual Symposium Event , taking place on Wednesday 10 November 2021.

During the presentation titled, ' Size selection of cell-free DNA enhances signal for the detection of tumor-specific variants in cancer patients', Kimberly Holden, Research Associate III at Labcorp, will demonstrate how Yourgene's Ranger(R) Technology is used with the NIMBUS Select platform to overcome historic challenges in circulating tumour DNA (ctDNA) variant detection. The N IMBUS Select is a proprietary instrument combining Yourgene's Ranger(R) Technology in partnership with the Microlab NIMBUS platform from Hamilton Company, a leading global instrument manufacturer.

Labroots Clinical Diagnostics and Research Virtual Event brings together clinicians, researchers, medical experts and professionals and aims to elevate the level of collaboration and in turn, advance clinical diagnostics, research and medicine. The Labroots event will include presentations on: Emerging Diagnostic Technologies, COVID-19 Screening and Diagnosis, Medical Imaging and The Labs Role in Advancing Equity. Yourgene will also be sponsoring a virtual booth at the event.

Investors can register to dial into the Labroots Webinar here:

Yourgene Health plc                                                   Tel: +44 (0)161 669 8122 
 Lyn Rees, Chief Executive Officer                      
Barry Hextall, Chief Financial Officer 
Joanne Cross, Director of Marketing 
Singer Capital Markets (Joint Corporate                               Tel: +44 (0)20 7496 3000 
Aubrey Powell / Tom Salvesen / George 
Stifel Nicolaus Europe Limited (Joint                                 Tel: +44 (0)20 7710 7600 
 Corporate Broker) 
Nicholas Moore / Matthew Blawat / Ben 
Walbrook PR Ltd (Media and Investor        Tel: +44 (0)20 7933 8780 or 
Paul McManus / Lianne Applegarth                            Mob: 07980 541 893 / 07584 391 303 
 / Alice Woodings                                                              / 07407 804 654 

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops integrated genomic technologies and services enabling precision medicine. The group works in partnership with global leaders in DNA technology to advance diagnostic science.

Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and now infectious diseases. The Group's flagship products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and a recent extension into the oncology space with DPYD genotyping.

The launch of Yourgene Genomic Services has enabled Yourgene to offer a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations to support partners at the preclinical, clinical, and post-market stages to develop, manufacture, obtain regulatory approval and commercialise new products and services. In addition, Yourgene Genomic Services offers an NIPT and high throughput COVID testing service.

In August 2020, Yourgene acquired Coastal Genomics , Inc., a sample preparation technology company based in Vancouver, Canada, enabling the Company to extend its offering and IP portfolio in the DNA sample preparation sector. The acquisition increased Yourgene's geographical penetration into the US and Canada, supplementing existing coverage in the UK, Europe, MEA and Asia.

Yourgene Health is headquartered in Manchester, UK with offices in Taipei, Singapore, the US and Canada, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit and follow us on twitter @Yourgene_Health.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

October 28, 2021 02:00 ET (06:00 GMT)

1 Year Premaitha Chart

1 Year Premaitha Chart

1 Month Premaitha Chart

1 Month Premaitha Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221006 05:01:32